Correlation Between Emergent Biosolutions and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and ProMIS Neurosciences, you can compare the effects of market volatilities on Emergent Biosolutions and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and ProMIS Neurosciences.
Diversification Opportunities for Emergent Biosolutions and ProMIS Neurosciences
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Emergent and ProMIS is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and ProMIS Neurosciences
Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 1.68 times more return on investment than ProMIS Neurosciences. However, Emergent Biosolutions is 1.68 times more volatile than ProMIS Neurosciences. It trades about 0.11 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about -0.29 per unit of risk. If you would invest 906.00 in Emergent Biosolutions on September 1, 2024 and sell it today you would earn a total of 106.00 from holding Emergent Biosolutions or generate 11.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Emergent Biosolutions vs. ProMIS Neurosciences
Performance |
| Timeline |
| Emergent Biosolutions |
| ProMIS Neurosciences |
Emergent Biosolutions and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Emergent Biosolutions and ProMIS Neurosciences
The main advantage of trading using opposite Emergent Biosolutions and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| Emergent Biosolutions vs. Tff Pharmaceuticals | Emergent Biosolutions vs. Eliem Therapeutics | Emergent Biosolutions vs. Inhibrx | Emergent Biosolutions vs. Enliven Therapeutics |
| ProMIS Neurosciences vs. Tff Pharmaceuticals | ProMIS Neurosciences vs. Eliem Therapeutics | ProMIS Neurosciences vs. Inhibrx | ProMIS Neurosciences vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |